News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Faster Pace Than Expected, Immunicum Completes Treatment of the Last Patient in Its Kidney Cancer Vaccine Phase I/II-Study Already in August



8/19/2013 9:03:38 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Faster pace than expected, Immunicum completes treatment of the last patient in its kidney cancer vaccine phase I/II-study already in August

Immunicum AB (publ) today announced that the last scheduled patient in the Company's phase I/II study in metastatic renal cancer has received the concluding dose of the cancer vaccine INTUVAX®.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES